Frontgrade Gaisler and wolfSSL Collaborate to Enhance Cybersecurity in Space Applications
3.4.2025 08:35:00 CEST | Business Wire | Press Release
Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, and wolfSSL, a renowned provider of embedded security solutions, are pleased to announce a new collaboration that addresses the growing need for robust cybersecurity features in space applications. This joint effort will combine Frontgrade Gaisler's radiation-hardened electronics with wolfSSL's security software libraries.
At the highest Technology Readiness Level of 9 (TRL-9), the Frontgrade Gaisler’s GR740 quad-core microprocessor is trusted across multiple space mission profiles. The microprocessor’s software ecosystem is now further enhanced by porting wolfSSL’s wolfCrypt robust cryptography library. This integration offers customers a combination of rad-hard hardware and resilient cybersecurity software. WolfSSL’s wolfCrypt library equips users with a lightweight, high-performance cryptographic solution that ensures secure communications, data integrity, and protection against cyber threats in space-based applications. Forward-thinking users will benefit from the support for post quantum cryptography and CNSA 2.0.
"We understand the growing need for secure solutions in space technology," said Sandi Habinc, General Manager at Frontgrade Gaisler. "By collaborating with wolfSSL, we are now enabling our customers with the reliable software needed to address their cybersecurity requirements."
"Security is paramount in space applications, where reliability and resilience are critical. By integrating wolfCrypt with Gaisler’s GR740 processor, we’re providing a proven, lightweight, and high-performance security solution that meets the unique challenges of space environments," said Larry Stefonic, Chief Executive Officer of wolfSSL. "We look forward to expanding our collaboration to bring even stronger cryptographic capabilities to future space missions."
Looking ahead, Frontgrade Gaisler and wolfSSL are excited to expand their collaboration. Planned future developments include a port of wolfHSM software to the Hardware Security Module (HSM) in Gaisler’s upcoming GR765 octa-core rad-hard microprocessor. The combination would create an isolated platform for key storage, signature verification, and crypto acceleration that would be easily accessible through wolfCrypt.
About Frontgrade Gaisler
Frontgrade Gaisler, a Frontgrade company, is a leading provider of radiation-hardened microprocessors and IP cores for critical applications, particularly in the space industry. The company’s processors are ideal for any space mission or other high-reliability application due to their reliability, fault tolerance, and radiation tolerance. Frontgrade Gaisler microprocessors can be found all over the solar system, from Mercury to Neptune.
About Frontgrade Technologies
Frontgrade Technologies is a leading provider of high-reliability, radiation-assured solutions for defense, intelligence, commercial, and civil applications. With over 60 years of space flight heritage, Frontgrade offers a complementary and integrated suite of mission-matched electronics, including rad-hard and rad-tolerant components, mission processing subsystems, amplifiers, custom ASICs, motion control systems, waveguides, antennas, and power management solutions. For more information, visit www.frontgrade.com.
About wolfSSL
wolfSSL is a leading provider of lightweight, embedded security solutions, delivering high-performance cryptography for government, automotive, avionics, and industrial applications. wolfSSL’s products comply with the latest industry standards, including TLS 1.3, DTLS 1.3, FIPS 140-3, Common Criteria, RTCA DO-178C Level A, and MISRA-C.
With a codebase up to 20x smaller than OpenSSL, a simple API, and an OpenSSL compatibility layer, wolfSSL provides unmatched efficiency and security. As an open-source provider, wolfSSL prioritizes transparency, offering customers the ability to inspect its cryptographic implementations.
Backed by the industry’s largest team of dedicated cryptographic engineers, wolfSSL delivers the fastest vulnerability patch times (<36 hours) and offers 24/7 commercial support.
For more information, visit wolfssl.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402856214/en/
Contacts
Media Contact:
Liz Ryan Sax
Frontgrade Technologies
+1 719-487-4259
press@frontgrade.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom